← back to search

Chao Cheng

Baylor College of Medicine · US
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Genomics and Chromatin Dynamics, and Gene expression and cancer classification.
h-index
61
citations
16,001
works
501
NIH funding
primary concept
email

Recent publications

Neoadjuvant Osimertinib for Resectable <i>EGFR</i> -Mutated Non–Small Cell Lung Cancer
Journal of Clinical Oncology 2025cited by 49position: middledoi
Dectin-1 facilitates lung fungal-mediated pulmonary fibrosis
Immunity 2025cited by 3position: middledoi
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
The Lancet Digital Health 2023cited by 107position: middledoi
High-throughput proteomics: a methodological mini-review
Laboratory Investigation 2022cited by 346position: middledoi
Cooperation of chromatin remodeling SWI/SNF complex and pioneer factor AP-1 shapes 3D enhancer landscapes
Nature Structural & Molecular Biology 2022cited by 117position: middledoi
VISTA Targeting of T-cell Quiescence and Myeloid Suppression Overcomes Adaptive Resistance
Cancer Immunology Research 2022cited by 46position: middledoi
LncRNA GAS5 regulates the Wnt/β-catenin pathway through the miR-18a-5p/AXIN2/GSK3β axis to inhibit the proliferation and migration of bladder cancer cells
Carcinogenesis 2022cited by 33position: middledoi
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
Nature Communications 2021cited by 216position: middledoi
Pan-cancer association of HLA gene expression with cancer prognosis and immunotherapy efficacy
British Journal of Cancer 2021cited by 207position: lastdoi
Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma
Immunity 2021cited by 162position: middledoi
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
Nature Communications 2021cited by 50position: middledoi
Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
Cancer Research 2021cited by 38position: lastdoi
VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance
Science 2020cited by 278position: middledoi
Transcriptional and proteomic insights into the host response in fatal COVID-19 cases
Proceedings of the National Academy of Sciences 2020cited by 213position: middledoi
An integrative ENCODE resource for cancer genomics
Nature Communications 2020cited by 183position: middledoi
Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy
Clinical Cancer Research 2020cited by 69position: middledoi
CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies
Cell Reports 2019cited by 211position: middledoi
H22954, a novel long non-coding RNA down-regulated in AML, inhibits cancer growth in a BCL-2-dependent mechanism
Cancer Letters 2019cited by 63position: middledoi
An integrative ENCODE resource for cancer genomics
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 15position: middledoi
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER <sup>+</sup> breast cancer
The FASEB Journal 2018cited by 31position: middledoi
A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis
Molecular Cancer Research 2018cited by 30position: lastdoi
Comparative analysis of the transcriptome across distant species
Nature 2014cited by 320position: middledoi
Comparative analysis of regulatory information and circuits across distant species
Nature 2014cited by 232position: middledoi
Analysis of clock-regulated genes in <i>Neurospora</i> reveals widespread posttranscriptional control of metabolic potential
Proceedings of the National Academy of Sciences 2014cited by 147position: middledoi
The Histone Methyltransferase Activity of MLL1 Is Dispensable for Hematopoiesis and Leukemogenesis
Cell Reports 2014cited by 133position: middledoi
A Comprehensive Nuclear Receptor Network for Breast Cancer Cells
Cell Reports 2013cited by 85position: middledoi
Architecture of the human regulatory network derived from ENCODE data
Nature 2012cited by 1,548position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Evelien Schaafsma · Dartmouth College4 papers (2018–2022)Yanding Zhao · Stanford University4 papers (2018–2022)J. Louise Lines · Dartmouth College2 papers (2020–2022)Christopher I. Amos · UNM Comprehensive Cancer Center2 papers (2018–2021)Randolph J. Noelle · Dartmouth College2 papers (2020–2022)Mohamed ElTanbouly · Dartmouth College2 papers (2020–2022)Elizabeth C. Nowak · Dartmouth College2 papers (2020–2022)Mary-Jo Turk · American University of Beirut Medical Center2 papers (2018–2021)Xin Huang · BGI Group (China)1 papers (2020–2020)Cecilia A. Webber · Harvard University1 papers (2022–2022)Bennett Wolf · Dartmouth College1 papers (2022–2022)Aaron Hawkes · Dartmouth College1 papers (2021–2021)Xiaofei Qi · Soochow University1 papers (2019–2019)Yaqi Duan · New York University1 papers (2020–2020)Aurélien Sarde · Wave 80 Biosciences (United States)1 papers (2022–2022)Yuanlin Guan · BGI Group (China)1 papers (2020–2020)Erika L. Artinger · Dartmouth College1 papers (2014–2014)Nicole A. Traphagen · Dartmouth College1 papers (2018–2018)Jay L. Rothstein · Amgen (United States)1 papers (2020–2020)Xiaoying Zhou · Dartmouth College1 papers (2014–2014)